Endpoints are the key outcomes by which we judge a trial or product’s success are the compass guiding clinical development. An endpoint that “survives reality” is one that remains meaningful and measurable when confronted with all the challenges outside a pristine lab environment. These challenges include things like measurement burden on participants, missing data, and imperfect patient adherence to using devices or apps. Too often, teams design what looks like a robust outcome on paper, only to have it fall apart in practice because participants find it too cumbersome, data collection falters, or patients simply don’t (or can’t) do what the protocol assumed they would. In this post, we explore how to pick endpoints that can weather real-world conditions. We’ll look at common failure points burden, missingness, adherence and how to simulate or “stress test” your endpoints against these realities before you launch. The goal is to arm founders with strategies to ensure their chosen success metrics remain valid outside of ideal scenarios.
When Perfect Endpoints Meet Imperfect Reality
Clinical trials traditionally operate in controlled settings: patients follow visit schedules, and trained staff ensure protocols are executed to the letter. Once you move from the clinic to the home, however, control dissipates. What does this mean for endpoint selection? It means that as a founder or trial designer, you have to anticipate the reality gap.
Measurement Burden; When Data Collection Overloads
the Patient
One of the most common reasons endpoints falter is measurement burden: the effort, time, or discomfort required from patients to capture the data. An endpoint that requires filling out a 30-question diary every day or coming in for weekly lab tests can exhaust and alienate participants. Research shows that if patient-reported outcome (PRO) questionnaires or other assessments are too onerous, patients simply stop completing them – undermining data completeness and quality.
Medication Adherence; The Human Factor that Kills
Projected Endpoints
Medication adherence research has long shown that patients often take only ~50% of doses for chronic treatments, not out of malice or lack of intelligence, but due to forgetfulness, side effects, life distractions, etc. Device adherence is no different. In one dramatic trial (the
defibrillator vest example), poor adherence nullified the device’s life-saving potential. But even in less extreme cases, variable adherence erodes the power of an endpoint. If an activity tracker is worn 24/7 by some participants and only “when convenient” by others, the data will be noisy and potentially biased (perhaps those feeling ill take the device off more often). Designers of successful digital endpoints often follow a key principle: make it as easy as possible for the user to adhere, and even better, make the device do the work. If planning an endpoint involving patient-operated tech like a medical device maybe, probe the weak points: Does the device need charging? If so, how often and can it survive a missed charge? Does it interfere with daily activities (e.g., a sleeve that can’t be worn in the shower)? Is
the data visible and useful to the patient (which might encourage use), or does it feel like data goes into a black hole? Answering these questions early can guide you to either choose a more user-friendly endpoint or put support structures in place (for instance, integrating monitoring and nudging: gentle reminders if no data is received for a while, escalating to a phone call if needed, a technique often used in digital health programs. One powerful approach is to monitor adherence in real time during the trial and intervene early. Many digital platforms now allow study teams to see usage dashboards. If a participant hasn’t generated any data from their smart inhaler in 3 days, you can reach out and ask if everything is okay.
Pre-Flight Simulation: Stress-Testing Your Endpoints
Given all these challenges, a wise team will ask: Can we test our chosen endpoint against reality before we roll it out in a costly trial or product launch? The answer is yes. Just as engineers stress-test a bridge or an airplane in simulations, clinical developers can stress-test endpoints and trial designs using simulation and digital twins. In fact, forward-looking sponsors today operate in what one expert calls a “living simulation” environment: digital patient twins that let you pressure-test endpoints and trial protocols before a single real patient is enrolled. Think of it as a dress rehearsal for your endpoint under real-world conditions.Simulation isn’t just about numbers; it can reveal qualitative failure points. In one illustrative project, designers were planning a trial for a new pain therapy. Through simulation, they discovered that if patients didn’t experience pain relief quickly, dropout rates would skyrocket, rendering the study futile. This prompted a change in the protocol to include an initial higher “loading dose” to provide earlier relief. The result? In the actual trial, patients indeed had early pain relief and stayed in the study, just as the simulation predicted a potential disaster averted.
A Quick Stress-Test Checklist:
● Burden Simulation: Can you experience your data collection process from a patient’s eyes? Time how long it takes, note any inconvenience. Now imagine doing that every day. If it seems tedious to you, it will be doubly so for a patient. Consider reducing
frequency or automating parts of the process.
● Missing Data Drill: Assume that X% of data will be missing (pick a reasonable number like 15% or use industry benchmarks). Remove that portion from a test dataset and see if your analysis still holds. If your endpoint is binary (success/fail), simulate different rates
of loss to follow-up and see if the efficacy signal stays above water.
● Adherence Scenarios: Envision best-case, average-case, and worst-case adherence scenarios. For instance: What if patients use the device correctly 90% of the time? 70%? Only 50%? At what point does the intervention effect wash out? This informs what minimum adherence you need – and thus how much support or incentive structure you might need to build to achieve it.
● Population Variability: Reality includes diverse patients – some will find your endpoint easy, others will struggle. Simulate how your endpoint performs across a variety of patient types (young vs old, tech-savvy vs not, mild disease vs severe, etc.). Does it work for all, or is it fragile in certain subgroups? This is especially crucial for global trials where cultural and language factors can affect responses and device use.
● Technology Fails: Assume that any technology used (wearable, app, etc.) will have a certain failure rate – devices will break, batteries will die, data will fail to transmit. What is the backup plan? Ensure that a few tech hiccups won’t derail the whole endpoint. Sometimes having a secondary way to measure the outcome (even if less precise) for those cases can save your data.
By conducting such stress tests, you essentially bulletproof your endpoint design. It’s far better
to iterate on the endpoint in the planning stage – adjusting the protocol, adding patient training,
improving device usability, or choosing a different metric – than to discover the flaw after months
of trial conduct.